What’s new at the Rosalind & Morris Goodman Cancer Institute?

We are pleased to welcome Dr. Simon F. Roy, M.D., M.H.S., to the Rosalind and Morris Goodman Cancer Institute (GCI) in a joint appointment with McGill University’s Department of Pathology.

Each year, the GCI welcomes a dynamic cohort of undergraduate research interns who spend their summers immersed in real-world cancer research. Working alongside leading scientists and graduate trainees, these students gain hands-on experience, develop new skills, and contribute meaningfully to projects in fields ranging from cancer genomics and immunology to metabolism, and bioengineering.

We are proud to announce that Molly Shen has been awarded a 2025 Vanier Canada Graduate Scholarship, one of the country’s most prestigious academic honours.

Rosalind and Morris Goodman Cancer Institute(GCI) alumna Meztli Arguello first discovered her passion for pharmaceutical research as an undergraduate intern at Merck Frosst. That early glimpse set the stage for a dynamic and rewarding career that would take her through cutting-edge academic labs and eventually into a leadership role in industry.

On June 18, the atrium of the Rosalind and Morris Goodman Cancer Institute (GCI) transformed into a vibrant, welcoming space for the GCI “Community Café”, a new event organized by the GCI's Equity, Diversity and Inclusion (EDI) Committee. More than 150 members of the GCI community gathered for this special moment of connection, designed to place community voices at the center of the GCI’s evolving EDI strategy.

Graduate student Ekkanat (Web) Jiramongkolsiri has been named the 2025 recipient of the Jerry Pelletier Studentship in Cancer Research, awarded by the Department of Biochemistry. This award recognizes a student whose work embodies the late Professor Jerry Pelletier’s dedication to cancer research, scientific excellence, and community engagement.

To mark its 20th anniversary, Cell Metabolism is spotlighting authors whose discoveries have helped define the field of metabolic research. Among the featured contributors is Lawrence Kazak, PhD, Principal Investigator at the Rosalind and Morris Goodman Cancer Institute (GCI), recognized for a study he conducted during his postdoctoral fellowship at Dana-Farber Cancer Institute and Harvard Medical School.

On June 5 and 6, 2025, members of the Rosalind and Morris Goodman Cancer Institute (GCI) community came together to celebrate Professor Nahum Sonenberg’s legacy of mentorship and to announce the creation of a second Sonenberg Postdoctoral Fellowship. The fellowship honours Professor Sonenberg, a scientist recognized for his foundational discoveries in mRNA biology and decades of mentorship.

A new study co-led by Morag Park, Ph.D., Rosalind and Morris Goodman Cancer Institute (GCI) Investigator and Director, and Christopher Moraes, Ph.D., Associate Member at the GCI, in collaboration with Jiannis Ragoussis, Ph.D., reveals important insights into the role of cancer-associated fibroblasts (CAFs) in the spread of triple-negative breast cancer.